AV7909

BIOLOGICAL5 trials

Sponsors

Emergent BioSolutions, Biomedical Advanced Research and Development Authority, National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

AnthraxAnthrax Immunisation

Phase 1

Anthrax AV7909 Liquid vs Lyophilized

CompletedNCT04660201

National Institute of Allergy and Infectious Diseases (NIAID)Anthrax, Anthrax Immunisation

Start: 2022-05-25End: 2024-03-30Updated: 2024-12-19

Phase 2

A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels

CompletedNCT01770743

Emergent BioSolutionsAnthrax

Start: 2013-01-31End: 2014-12-31Updated: 2024-03-18

BARDA Securing Anthrax Immunity For the Elderly

CompletedNCT03518125

Biomedical Advanced Research and Development AuthorityAnthrax

Start: 2018-05-09End: 2019-12-09Updated: 2020-07-21

Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study

CompletedNCT04067011

Emergent BioSolutionsAnthrax

Start: 2019-08-12End: 2020-03-19Updated: 2025-09-08

Phase 3

VELOCITY: An Anthrax Vaccine Clinical Study

CompletedNCT03877926

Emergent BioSolutionsAnthrax

Start: 2019-03-11End: 2020-08-06Updated: 2024-03-18

Related Papers

Effect of Co-administration of the anthrax vaccine adsorbed, adjuvanted with ciprofloxacin or doxycycline on antibiotic pharmacokinetics and the vaccine immunogenicity: A phase 2 drug-vaccine interaction study.

2025-12-24

Immunogenicity, safety, and lot consistency of the anthrax vaccine adsorbed, adjuvanted for post-exposure prophylaxis of anthrax in healthy adults: A phase 3, randomized, double-blind trial.

2025-12-15

368. A Phase 3, Randomized, Double-blind, Parallel-group Trial to Evaluate the Immunogenicity and Safety of AV7909 for Post-exposure Prophylaxis of Anthrax in Healthy Adults

Open Forum Infectious Diseases2023-11-27

1159. A Phase 2 Drug-Vaccine Interaction Study of AV7909 and Ciprofloxacin or Doxycycline on Antibiotic Pharmacokinetics

Open Forum Infectious Diseases2023-11-27

Evaluation of BioThrax® and AV7909 anthrax vaccines in adults 66 years of age or older

Vaccine2020-10-2813 citations